Table 1.
Isolates | CN | CIP | K | VA | C | STM | IPM | MEM | NA | CFM | FEP | LZD | SXT | RIF | AK | TE | AMC |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFS1 | R | R | R | R | S | R | S | S | S | R | R | S | R | S | R | R | S |
PFS2 | R | R | R | R | S | R | S | S | S | R | R | S | S | S | R | S | S |
PFS3 | R | S | R | R | R | R | S | I | S | R | R | S | R | S | R | S | I |
PFS4 | S | S | R | R | S | R | S | S | S | S | S | S | S | S | S | S | S |
PFS5 | R | S | R | R | R | R | S | S | S | R | R | S | R | S | R | R | S |
PFS6 | R | R | R | R | S | S | S | S | S | S | R | S | R | S | S | S | I |
PFS7 | R | S | R | R | R | R | S | S | S | R | R | S | R | S | R | R | I |
PFS8 | R | R | R | R | S | R | S | S | S | R | R | S | I | S | R | S | S |
PFS9 | R | S | R | R | I | R | S | S | S | R | I | S | I | S | R | R | R |
PFS10 | R | S | R | S | S | R | S | S | S | R | I | S | I | S | R | S | I |
PFS11 | S | S | R | S | S | R | S | S | S | R | R | S | R | S | R | S | R |
PFS12 | R | S | R | S | R | S | S | S | S | R | R | S | I | S | R | S | S |
PFS13 | S | S | R | S | S | S | S | S | S | S | S | S | S | S | S | R | S |
PFS14 | S | S | R | S | S | R | S | S | S | S | S | S | S | S | S | S | S |
PFS15 | S | R | R | R | S | R | S | S | S | R | R | S | R | S | R | R | S |
PFS16 | S | S | R | R | S | R | S | R | S | R | I | S | I | S | R | I | S |
PFS17 | S | S | R | S | S | R | S | I | S | R | R | S | I | S | R | I | S |
Abbreviations: C—chloramphenicol (30 μg); AMC—amoxicillin-clavulanic acid (10 μg); CIP—ciprofloxacin(10 μg); CN—gentamicin (10 μg); SXT—trimethoprim/sulfamethoxazole (25 μg); K—kanamycin (30 μg); MEM—meropenem (10 μg); IPM—imipenem (10 μg); FEP—cefepime (30 μg); CFM—cefixime (5 μg); LZD—linezolid (30 μg); NA—nalidixic acid (30 μg); VA—vancomycin (30 μg); RIF—rifampicin (30 μg); Ak—amikacin (10 μg); TE—tetracycline (30 μg); STM—streptomycin (5 μg); R—resistance; S—sensitivity; I—intermediate.